Vascular Risk Factors, Endothelial Function, and Carotid Thickness in Patients with Migraine: Relationship to Atherosclerosis

Journal of Stroke and Cerebrovascular Diseases

Volumn 19, Issue 2, 2010, Pages 92-103

  Hamed, Sherifa A ^a   Hamed, Enas A ^a   Ezz Eldin, Azza M ^b   Mahmoud, Nagia M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

atherosclerosis; brachial artery flow mediated dilatation; carotid artery intima media thickness; endothelin 1; Migraine; vascular risk factors

Indexed keywords

ANTIMIGRAINE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIN 1; GLUCOSE; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTHELIUM INJURY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TENSION HEADACHE; TRANSFORMED MIGRAINE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; COMORBIDITY; DIABETES COMPLICATIONS; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MALE; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; RISK FACTORS; TRIGLYCERIDES; TUNICA INTIMA; VASOCONSTRICTION;

EID: 77049115456     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.04.007     Document Type: Article

References (40)

1. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: Data from the American migraine study II. Headache 41 (2001) 646-657
2. Olesen J. The international classification of headache disorders, 2nd edition: Application to practice. Funct Neurol 20 (2005) 61-68
3. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine-current understanding and treatment. N Engl J Med 346 (2002) 257-270
4. Bigal M.E., Gironda M., Tepper S.J., et al. Headache prevention outcome and body mass index. Cephalalgia 26 (2006) 445-450
5. Bic Z., Blix G.G., Hopp H.P., et al. The influence of a low fat-diet on incidence and severity of migraine headaches. J Womens Heath Gend Based Med 8 (1999) 623-630
6. Cirillo M., Stellanto D., Lombardi C., et al. Headache and cardiovascular risk factors: Positive association with hypertension. Headache 39 (1999) 409-416
7. Rainero I., Limone P., Ferrero M., et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 25 (2005) 593-597
8. Schwaag S., Nabavi D.G., Frese A., et al. The association between migraine and juvenile stroke: A case-control study. Headache 43 (2003) 90-93
9. Scher A.I., Terwindt G.M., Picavet H.S., et al. Cardiovascular risk factors in migraine: The GEM population-based study. Neurology 19 (2005) 683-692
10. Hamed S.A. The vascular risk associations with migraine: Relation to migraine susceptibility and progression. Atherosclerosis 205 (2009) 15-22
11. Sarchielli P., Alberti A., Baldi A., et al. Proinflammatory cytokines, adhesion molecules and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46 (2006) 200-207
12. Little P.J., Ivey M.E., and Osman N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr Vasc Pharmacol 6 (2008) 195-203
13. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39 (2002) 257-265
14. Raitakari O.T. Imaging of subclinical atherosclerosis in children and young adults. Ann Med 31 (1999) 33-40
15. Gudmundsson L.S., Thorgeirsson G., Sigfusson N., et al. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects: The Reykjavik study. Cephalalgia 26 (2006) 436-444
16. Baldrati A., Bini L., D'Alessandro R., et al. Analysis of outcome predictors of migraine towards chronicity. Cephalalgia 5 (1985) 195-199
17. Horev A., Wirguin I., Lantsberg L., et al. A high incidence of migraine with aura among morbidly obese women. Headache 45 (2005) 936-938
18. Glueck C.J., and Bates S.R. Migraine in children: Association with primary and familial dyslipoproteinemias. Pediatrics 77 (1986) 316-321
19. Welch K.M., Brandes A.W., Salerno L., et al. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 46 (2006) 197-199
20. Vanmolkot F.H., and de Hoon J.N. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27 (2007) 843-846
21. Hingorani A.D., Shah T., Casas J.P., et al. C-reactive protein and coronary heart disease: Predictive test or therapeutic target?. Clin Chem 55 (2009) 239-255
22. Ryu S.R., Choi I.S., Bian R.X., et al. The effect of C-reactive protein on functional outcome in ischemic stroke patients. Int J Neurosci 119 (2009) 336-344
23. McCarthy L.C., Hosford D.A., Riley J.H., et al. Single nucleotide polymorphism [SNP] alleles in the insulin receptor gene (INSR) are associated with migraine. Genomics 78 (2001) 135-149
24. Watson K.E., Peters Harmel A.L., and Matson G. Atherosclerosis in type 2 diabetes mellitus: The role of insulin resistance. J Cardiovasc Pharmacol Ther 8 (2003) 253-260
25. Miyauchi T., and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61 (1999) 391-415
26. Hamed E.A., Meki A.R.M., Gaafar A.A., et al. Role of some vasoactive mediators in patients with erectile dysfunction: Their relationship with angiotensin-converting enzyme and growth hormone. Int J Impot Res 15 (2003) 418-425
27. Elmarakby A.A., Loomis E.D., Pollock J.S., et al. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 (2005) 283-287
28. Campuzano R., Moya J.L., García-Lledó A., et al. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 24 (2006) 1581-1588
29. Celermajer D.S., Sorensen K.E., Bull C., et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24 (1994) 1468-1474
30. Leeson P., Thorne S., Donald A., et al. Non-invasive measurement of endothelial function: Effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 78 (1997) 22-27
31. Iversen H.K., Nielsen T.H., Olesen J., et al. Arterial responses during migraine headache. Lancet 336 (1990) 837-839
32. de Hoon J.N., Willigers J.M., Troost J., et al. Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia 23 (2003) 96-104
33. Yetkin E., Ozisik H., Ozcan C., et al. Increased dilator response to nitrate and decreased flow-mediated dilatation in migraineurs. Headache 47 (2007) 104-110
34. Baldassarre D., Amato M., Bondioli A., et al. Carotid artery intimal-medial thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 31 (2000) 2426-2430
35. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular health study collaborative research group. N Engl J Med 340 (1999) 14-22
36. Kurth T., Schürks M., Logroscino G., et al. Migraine, vascular risk, and cardiovascular events in women: Prospective cohort study. BMJ 337 (2008) a636
37. Bigal M.E., Sheftell F.D., Rapoport A.M., et al. Chronic daily headache: Identification of factors associated with induction and transformation. Headache 42 (2002) 575-581
38. Schrader H., Stovner L.J., Helde G., et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): Randomized, placebo controlled, crossover study. BMJ 322 (2001) 19-22
39. Bunout D., Garrido A., Suazo M., et al. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition 16 (2000) 107-110
40. Liberopoulos E.N., and Mikhailidis D.P. Could statins be useful in the treatment of patients with migraine. Headache 46 (2006) 672-675